Bio-Fd&c

At a glance

Bio-Fd&c filed 19 disclosures in the last 12 months, including 5 5% holder. The most recent key filing was on Oct 6.

Revenue for 2025 was ₩19.2B, up 19.4% on 2024. Operating margin was 32.6% against 30.2% a year earlier. Debt was 5% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩9.4B and operating profit of ₩3.1B.

The 2025 annual report lists 78 employees with an average tenure of 4.9 years and average pay of ₩55.6M, #1196 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩122.9M each on average. It paid no cash dividend for 2025. 모상현 and related parties held 31.22% at year end.

From the 2025 annual report

Staff: 78 (36 men, 42 women), of whom 4 on fixed-term contracts. Total pay for the year: ₩4.3B. Directors and auditors: 6, paid ₩737.5M in total.

No cash dividend was paid for 2025.

Largest shareholder

모상현 holds 14.30%; with 10 related parties the group holds 31.22% of common shares at year end (from 31.39% at the start of the year).

Auditor: 동성회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary